Survival relative to pacemaker status after transcatheter aortic valve implantation

To determine whether a permanent pacemaker (PPM) in situ can enhance survival after transcatheter aortic valve implantation (TAVI), in a predominantly inoperable or high risk cohort.

[1]  P. Stella,et al.  Late onset of new conduction disturbances requiring permanent pacemaker implantation following TAVI , 2020, Heart.

[2]  T. Nazif,et al.  Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis. , 2020, European heart journal.

[3]  L. W. Andersen,et al.  Five-Year Clinical and Echocardiographic Outcomes from the Nordic Aortic Valve Intervention (NOTION) Randomized Clinical Trial in Lower Surgical Risk Patients. , 2019, Circulation.

[4]  Helmut Baumgartner,et al.  [2017 ESC/EACTS Guidelines for the management of valvular heart disease]. , 2017, Kardiologia polska.

[5]  S. Kapadia,et al.  Clinical and Echocardiographic Outcomes Following Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: Meta-Analysis and Meta-Regression , 2017, Circulation. Cardiovascular interventions.

[6]  P. Jüni,et al.  Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[7]  Andrew S. Mugglin,et al.  Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.

[8]  S. Rosenkranz,et al.  Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3. , 2016, JACC. Cardiovascular interventions.

[9]  A. Olowoyeye,et al.  Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. , 2016, JACC. Cardiovascular interventions.

[10]  P. Wenaweser,et al.  The Electrocardiogram After Transcatheter Aortic Valve Replacement Determines the Risk for Post-Procedural High-Degree AV Block and the Need for Telemetry Monitoring. , 2016, JACC. Cardiovascular interventions.

[11]  A. Regueiro,et al.  Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis , 2016, Circulation. Cardiovascular interventions.

[12]  H. Baumgartner,et al.  Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height. , 2016, JACC. Cardiovascular interventions.

[13]  C. Hengstenberg,et al.  Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve. , 2016, JACC. Cardiovascular interventions.

[14]  V. Thourani,et al.  Arrhythmia Burden in Elderly Patients With Severe Aortic Stenosis as Determined by Continuous Electrocardiographic Recording: Toward a Better Understanding of Arrhythmic Events After Transcatheter Aortic Valve Replacement , 2014, Circulation.

[15]  Peter Jüni,et al.  Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. , 2014, Journal of the American College of Cardiology.

[16]  J. Webb,et al.  Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation: Impact on Late Clinical Outcomes and Left Ventricular Function , 2013, Circulation.

[17]  H. Katus,et al.  Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve® aortic bioprosthesis , 2012, Clinical Research in Cardiology.

[18]  A. Cook,et al.  Permanent Pacemaker Insertion After CoreValve Transcatheter Aortic Valve Implantation: Incidence and Contributing Factors (the UK CoreValve Collaborative) , 2011, Circulation.

[19]  J. Caro.  ESC/EACTS Guidelines on the management of valvular heart disease , 2012 .